Xiaoling Cai
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Diabetes Treatment and Management 67
- Diabetes Management and Research 22
- Diabetes, Cardiovascular Risks, and Lipoproteins 20
- Genetics 24
- Diabetes and associated disorders 15
- Genetic Associations and Epidemiology 8
- Co-authors
- Linong Ji (98 shared papers)Wenjia Yang (63 shared papers)Xueyao Han (68 shared papers)Linong Ji (41 shared papers)Xueying Gao (17 shared papers)Fang Lv (47 shared papers)Chu Lin (52 shared papers)Yifei Chen (8 shared papers)
- Journals
- Frontiers in Endocrinology (9 papers)Diabetes Obesity and Metabolism (8 papers)Journal of Diabetes (7 papers)PLoS ONE (6 papers)Scientific Reports (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaoling Cai
178 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 109
- Endocrinology, Diabetes and Metabolism 1k
- Pharmacology 356
- Ophthalmology 146
- Nephrology 143
- Orthopedics and Sports Medicine 90
Countries citing papers authored by Xiaoling Cai
This map shows the geographic impact of Xiaoling Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Cai more than expected).
Fields of papers citing papers by Xiaoling Cai
This network shows the impact of papers produced by Xiaoling Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Cai. The network helps show where Xiaoling Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 149 | |
| 2 | 2008 | 147 | |
| 3 | 2019 | 90 | |
| 4 | 2018 | 88 | |
| 5 | 2009 | 87 | |
| 6 | 2019 | 85 | |
| 7 | 2009 | 83 | |
| 8 | 2020 | 78 | |
| 9 | 2015 | 56 | |
| 10 | 2017 | 54 | |
| 11 | 2017 | 52 | |
| 12 | 2021 | 51 | |
| 13 | 2017 | 48 | |
| 14 | 2017 | 48 | |
| 15 | 2014 | 47 | |
| 16 | 2006 | 45 | |
| 17 | 2024 | 41 | |
| 18 | 2011 | 39 | |
| 19 | 2019 | 39 | |
| 20 | 2014 | 38 |
About Xiaoling Cai
Xiaoling Cai is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Nephrology, Pharmacology and Surgery, having authored 188 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (67 papers), Diabetes Management and Research (22 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Diabetes and associated disorders (15 papers), Chronic Kidney Disease and Diabetes (11 papers), Pancreatic function and diabetes (11 papers), Genetic Associations and Epidemiology (8 papers) and Bone health and osteoporosis research (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1k citations), Pharmacology (356 citations), Ophthalmology (146 citations), Nephrology (143 citations) and Orthopedics and Sports Medicine (90 citations). Xiaoling Cai has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Linong Ji, Wenjia Yang, Xueyao Han, Linong Ji, Xueying Gao, Fang Lv, Chu Lin, Yifei Chen, Simin Zhang and Yongcheng Lin. Their work appears in journals such as Frontiers in Endocrinology, Diabetes Obesity and Metabolism, Journal of Diabetes, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.